| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10015194 | HBV | ENSG00000023909.10 | protein_coding | GCLM | No | No | 2730 | P48507 |
| TVIS10025887 | HBV | ENSG00000023909.10 | protein_coding | GCLM | No | No | 2730 | P48507 |
| TVIS30024425 | HIV | ENSG00000023909.10 | protein_coding | GCLM | No | No | 2730 | P48507 |
| TVIS30024426 | HIV | ENSG00000023909.10 | protein_coding | GCLM | No | No | 2730 | P48507 |
| TVIS30024427 | HIV | ENSG00000023909.10 | protein_coding | GCLM | No | No | 2730 | P48507 |
| TVIS20039435 | HPV | ENSG00000023909.10 | protein_coding | GCLM | No | No | 2730 | P48507 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GCLM |
|---|---|
| DrugBank ID | DB00142 |
| Drug Name | Glutamic acid |
| Target ID | BE0000606 |
| UniProt ID | P48507 |
| Regulation Type | |
| PubMed IDs | 17000861 |
| Citations | Giordano G, White CC, McConnachie LA, Fernandez C, Kavanagh TJ, Costa LG: Neurotoxicity of domoic Acid in cerebellar granule neurons in a genetic model of glutathione deficiency. Mol Pharmacol. 2006 Dec;70(6):2116-26. Epub 2006 Sep 25. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Glutamic acid and derivatives |
| SMILES | N[C@@H](CCC(O)=O)C(O)=O |
| Pathways | Histidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Purine Nucleoside Phosphorylase Deficiency; Tyrosine Metabolism; Ketoprofen Action Pathway; Glutamate Metabolism; Argininosuccinic Aciduria; Salla Disease/Infantile Sialic Acid Storage Disease; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Celecoxib Action Pathway; Glycine and Serine Metabolism; Suprofen Action Pathway; Indomethacin Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Sialuria or French Type Sialuria; Ibuprofen Action Pathway; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Arginine and Proline Metabolism; Purine Metabolism; Diflunisal Action Pathway; Etodolac Action Pathway; Ammonia Recycling |
| PharmGKB | PA449776 |
| ChEMBL | CHEMBL575060 |
